CLINICAL_TRIALS
trial_result
· 2013-04-15
Clinical Trial Update: A Study to Assess CH1504 in Patients With Active Rheumatoid Arthritis [Phase 2]
Summary
A Phase 2 clinical trial evaluating CH1504 in patients with active rheumatoid arthritis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chelsea Therapeutics | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED